Divis Laboratories has informed that a meeting of Board of Directors of the Company is scheduled to be held on February 04, 2017, to consider and approve the un-audited financial results for the quarter and nine months ended December 31, 2016(Q3). Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from January 28, 2017 to February 06, 2017 as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1933.10 |
| Dr. Reddys Labs. | 1210.85 |
| Cipla | 1418.40 |
| Lupin | 2442.10 |
| Zydus Lifesciences | 1142.75 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: